Novavax Inc vs Progressive Corp — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Progressive Corp trades at $207.39 (market cap $123.39B). The key difference: Progressive Corp is far larger — about 94.9× Novavax Inc's market cap, and Progressive Corp pays a 6.55% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | PGR | |
|---|---|---|
Market Cap | $1.30B | $123.39B |
Sector | Health | Financials |
52-Week High | $11.19 | $252.68 |
52-Week Low | $6.22 | $190.40 |
Enterprise Value | $800.50M | $131.61B |
Dividend Yield | — | 6.55% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →